A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001).
Saved in:
| Title: | A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001). |
|---|---|
| Authors: | Chen HJ; Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong Lung Cancer Institute, Southern Medical University, Guangzhou, China., Tu HY; Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong Lung Cancer Institute, Southern Medical University, Guangzhou, China., Hu Y; Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China., Fan Y; Department of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Wu G; Department of Medical Oncology, Meizhou People's Hospital (Huangtang Hospital), Meizhou, China., Cang S; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou, China., Yang Y; Department of Thoracic Surgery, The Third People's Hospital of Chengdu, Chengdu, China., Yang N; Department of Oncology, The Second People's Hospital of Hunan, Changsha, China., Ma R; Department of Thoracic Oncology, Liaoning Cancer Hospital & Institute, Shenyang, China., Jin G; Department of Medical Oncology, Inner Mongolia Autonomous Region People's Hospital, Huhhot, China., Xu X; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China., Liu A; Department of Medical Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China., Tang S; Department of Oncology, The First People's Hospital of Neijiang, Neijiang, China., Cheng Y; Department of Oncology, Jilin Cancer Hospital, Changchun, China., Yu Y; Department of Thoracic Medicine, Harbin Medical University Cancer Hospital, Harbin, China., Xu CR; Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong Lung Cancer Institute, Southern Medical University, Guangzhou, China., Zhou Q; Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong Lung Cancer Institute, Southern Medical University, Guangzhou, China., Wu YL; Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong Lung Cancer Institute, Southern Medical University, Guangzhou, China. syylwu@live.cn. |
| Source: | Journal of hematology & oncology [J Hematol Oncol] 2025 Jan 05; Vol. 18 (1), pp. 3. Date of Electronic Publication: 2025 Jan 05. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
